By Ruchika Sharma
Copyright medicaldialogues
New Delhi: Roche Pharma has announced that it has joined hands with ten government hospitals to strengthen India’s clinical trial ecosystem.Under this initiative, nearly 400 professionals—including investigators, ethics committee members, and other resources—have been trained as per global Good Clinical Practice (GCP) standards, PTI reported.”By equipping leading government hospitals with global-standard clinical trial capabilities, we are helping to bring innovations faster to India. This is a crucial step toward building equitable healthcare and shaping treatments that are relevant for India,” said Sivabalan Sivanesan, Country Medical Director, Roche Pharma India.The Advanced Inclusive Research (AIR) Site Alliance is Roche’s flagship global initiative designed to expand access to clinical trials for underrepresented populations.Already implemented in the US, the UK, Canada, and Africa, the AIR Site Alliance is now active in India.India accounts for 17 per cent of the world’s population and 20 per cent of the global disease burden, yet fewer than 4 per cent of global clinical trials are conducted in the country.The Initiative aligns with CDSCO priorities to boost participation of government sites in Phase 3 and 4 trials.Read also: Roche Pharma India appoints Rajwinder (Rajji) Mehdwan as new Country General ManagerIn March last year, Roche Pharma India forayed into the Ophthalmology space by launching Vabysmo (faricimab) for the treatment of eye diseases.Neovascular or wet age-related macular degeneration (nAMD) and diabetic macular edema (DME), are two leading causes of vision loss worldwide.Vabysmo is the dual-pathway-inhibitor that uniquely targets and inhibits two disease pathways linked to a number of vision threatening retinal conditions. It neutralises both angiopoietin-2 (Ang-2) and vascular endothelial growth factor-A (VEGF-A) which are key proteins involved in the development and progression of retinal conditions, contributing to vision loss by destabilising blood vessels in the eye. Read also: Roche Pharma India forays into Ophthalmology space with launch of Vabysmo
